… patients before and after SARS-CoV-2 infections are summarized in Tables 2 and 3, S2 and
S3. The majority of patients … 89.4%, except for two patients with STK4 and IL1RN deficiencies…

… SARS-CoV-2 infection has now a global resonance. Data on how COVID-19 is affecting
immunocompromised patients … review the current knowledge on SARS-CoV-2 cases in children …

… This work sought to determine recurrent mutations across the SARS-CoV-2 genome
associated with long-term infections in immunodeficient patients. This study has several notable …

… SARS-CoV-2-associated morbidity and mortality due to immunologic deficits that limit prevention,
treatment, and clearance of the virus. … of immunologic vulnerability to SARS-CoV-2 and …

… SARS-CoV-2 replication generating new variants of concern in immunodeficient patients has
… The results of a UK cohort that included 117 primary immune deficient patients were similar …

… the SARS-CoV-2-specific mAb bamlanivimab in patients at increased risk for severe course
of COVID-19, we observed viral rebound in five of six severely immunodeficient patients …

… patient showed more severe disease with the second infection than with the first, especially
because the patient … Reinfection of SARS-CoV-2 in an immunocompromised patient: a case …

… patients receiving treatment with the antiviral agent. We present a case of an
immunocompromised patient … an indolent, protracted course of SARS-CoV-2 infection. Remdesivir …

… immunodeficiency, and nonimmunocompromised groups (P < 0.01). Participants who
were severely immunocompromised had greater SARS-CoV-2 … had diminished SARS-CoV-2–…

… Thus, continuous surveillance of viral evolution in patients who are immunocompromised
could be important to improve preparedness for the potential emergence of new SARS-CoV-2 …